Cargando…
The Effect of Metformin on the Myocardial Tolerance to Ischemia-Reperfusion Injury in the Rat Model of Diabetes Mellitus Type II
In recent years, evidence has been accumulated that metformin, an antidiabetic drug in the biguanide class, in addition to its well-recognized glucose-lowering effect, can also reduce cardiovascular mortality in the patients with type 2 diabetes mellitus (T2DM). Besides, there are a few experimental...
Autores principales: | Kravchuk, Ekaterina, Grineva, Elena, Bairamov, Alekber, Galagudza, Michael, Vlasov, Timur |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3132893/ https://www.ncbi.nlm.nih.gov/pubmed/21754920 http://dx.doi.org/10.1155/2011/907496 |
Ejemplares similares
-
Effects of glucagon-like peptide 1 analogs in combination with insulin on myocardial infarct size in rats with type 2 diabetes mellitus
por: Zykov, Vladislav A, et al.
Publicado: (2018) -
Hyperleptinemia results in systemic inflammation and the exacerbation of ischemia-reperfusion myocardial injury
por: Polyakova, Ekaterina A., et al.
Publicado: (2021) -
Comparative evaluation of metformin and liraglutide cardioprotective effect in rats with impaired glucose tolerance
por: Simanenkova, Anna, et al.
Publicado: (2021) -
Effect of Metformin on Myocardial Injury Induced by Hepatic Ischemia-Reperfusion in Rats
por: An, Wen, et al.
Publicado: (2022) -
Myocardial protection against global ischemia with Krebs-Henseleit buffer-based cardioplegic solution
por: Minasian, Sarkis M, et al.
Publicado: (2013)